References
- Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–24. Epub 2011 Apr 19
- Broer S, Willem B, Hendricks D, Broekmans F. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009;91:705–14
- Van Disseldorp J, Lambalk CB, Kwee J, et al. Comparison of inter- and intra-cycle variability of anti-Müllerian hormone and antral follicle counts. Hum Reprod 2010;25:221–7
- Broer SL, Dólleman M, Opmeer BC, et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update 2011;17:46–54
- Stoop D, De Munck N, Jansen E, et al. Clinical validation of a closed vitrification system in an oocyte-donation programme. Reprod Biomed Online 2012;24:180–5
- Martínez F, Clua E, Parera N, et al. Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients. Gynecol Endocrinol 2008;24:188–93
- Martínez F, Clua E, Santmartí P, et al. Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors. Fertil Steril 2010;6:2433–6. [Epub 2010 Apr 28]
- Tan R, Pu D, Liu L, et al. Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization. Fertil Steril 2011;96:905–11. [Epub 2011 Aug 16]
- Anckaert E, Smitz J, Schiettecatte J, Klein BM, Arce JC. The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments. Hum Reprod 2012;27:1829–39. [Epub 2012 Apr 3]
- Bodri D, Sunkara SK, Coomarasamy A. Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis. Fertil Steril 2011;95:164–9
- Rigby RA, Stasinopoulos DM. Generalized additive models for location, scale and shape, (with discussion). Appl Statist 2005;54:507–54
- Voudouris V, Gilchrist R, Rigby R, et al. Modelling skewness and kurtosis with the BCPE density in GAMLSS. J Appl Stat (forthcoming) 2012;12:1279--93
- R. Development Core Team: a language and environment for statistical computing. R Foundation for Statistical Computing, 2007. Vienna, Austria. ISBN 3-900051-07-0, Available at: http://www.R-project.org
- Nelson SM, Messow MC, Wallace AM, et al. Nomogram for the decline in serum antimüllerian hormone: a population study of 9601 infertility patients. Fertil Steril 2011b;95:736–41
- Kelsey TW, Wright P, Nelson SM, et al. A validated model of serum anti-müllerian hormone from conception to menopause. PLoS One 2011;6:e22024. Published online 2011 July 15. doi: 10.1371/journal.pone.0022024PMCID: PMC3137624
- Lie Fong S, Visser JA, Welt CK, et al. Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab 2012;97:4650–55. [Epub 2012 Sep 19]
- Polyzos NP, Stoop D, Blockeel C, et al. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors. Reprod Biomed Online 2012;24:532–9. doi: 10.1016/j.rbmo.2012.01.024. [Epub 2012 Feb 3]
- Riggs R, Kimble T, Oehninger S, et al. Anti-Müllerian hormone serum levels predicti response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril 2011;95:410–12